(19)
(11) EP 1 511 713 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.02.2012 Bulletin 2012/06

(45) Mention of the grant of the patent:
17.08.2011 Bulletin 2011/33

(21) Application number: 03757173.4

(22) Date of filing: 06.06.2003
(51) International Patent Classification (IPC): 
C07C 327/26(2006.01)
C07C 69/76(2006.01)
A61K 31/265(2006.01)
 C07C 327/36(2006.01)
A61K 31/216(2006.01)
(86) International application number:
PCT/IB2003/003164
(87) International publication number:
WO 2003/104181 (18.12.2003 Gazette 2003/51)

(54)

COMPOUNDS THAT ABROGATE DNA-DAMAGE-INDUCED CELL CYCLE G2 CHECKPOINT AND/OR AUGMENT THE ANTI-CANCER ACTIVITY OF DNA-DAMAGING TREATMENTS

VERBINDUNGEN, DIE DEN DURCH DNA-SCHÄDIGUNG INDUZIERTEN G2-CHECKPOINT DES ZELLZYKLUS STILLLEGEN UND/ODER DIE ANTIKREBSWIRKUNG VON DNA-SCHÄDIGENDEN BEHANDLUNGEN ERHÖHEN

COMPOSES QUI SUPPRIMENT LE POINT DE CONTROLE G2 DU CYCLE CELLULAIRE INDUIT PAR L'ADN ENDOMMAGE ET/OU QUI ACCROIT L'ACTIVITE ANTI-CANCEREUSE DES TRAITEMENTS ENDOMMAGEANT L'ADN

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 06.06.2002 US 386930 P

(43) Date of publication of application:
09.03.2005 Bulletin 2005/10

(73) Proprietor: CanBas Co. Ltd.
Numazu Shizuoka 410-0801 (JP)

(72) Inventors:
  • KAWABE, Takumi
    Numazu, Shizuoka 410-0011 (JP)
  • KOBAYASHI, Hidetaka
    Numazu 410-0047 (JP)

(74) Representative: Baldock, Sharon Claire et al
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)


(56) References cited: : 
EP-A- 0 409 728
WO-A-97/46228
WO-A-99/47522
DE-A- 2 049 865
US-B1- 6 211 164
 WO-A-01/21771
WO-A-99/15157
WO-A-99/48495
US-A- 4 394 389
   
  • CHEMICAL ABSTRACTS, vol. 58, no. 6, 18 March 1963 (1963-03-18) Columbus, Ohio, US; abstract no. 5563c, K. C. JOSHI ET AL.: "Synthesis of fluorobenzoates as possible pesticides." page 5563; column 1; XP002266801 & J. INDIAN CHEM. SOC., vol. 39, no. 7, 1962, pages 495-496,
  • CHEMICAL ABSTRACTS, vol. 58, no. 4, 18 February 1963 (1963-02-18) Columbus, Ohio, US; abstract no. 3341g, S. D. JOLAD ET AL.: "Substituted benzophenones." page 3341; column 1; XP002266802 & J. KARNATAK UNIV., vol. 5, 1960, pages 1-9,
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 2274611 (BRN), XP002266804 & J. ORG. CHEM., vol. 41, 1976, page 2443
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 2583565 (BRN), XP002266805 & ARCH. PHARM. BER. DTSCH. PHARM. GES., vol. 296, 1963, pages 522-527,
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 6608813 (BRN), XP002266806 & J. ORG. CHEM. USSR (ENGL. TRANSL.), vol. 28, no. 8.2, 1992, pages 1339-1344,
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 2649250 , 2585603 (BRN), XP002266807 & ANAL. CHEM., vol. 56, no. 12, 1984, pages 2038-2043,
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 2120541 (BRN), XP002266808 & J. PRAKT. CHEM., vol. 321, 1979, page 969,973
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 3295520 (BRN), XP002266809 & J. ORG. CHEM., vol. 21, 1956, page 671
  • DATABASE CROSSFIRE BEILSTEIN [Online] BEILSTEIN INSTITUT ZUR FOEDERUNG DER CHEMISCHEN WISSENSCHAFTEN, FRANKFURT AM MAIN, DE; Database-Accession no. 2121991 (BRN), XP002266810 & TETRAHEDRON., vol. 47, no. 4/5, 1991, pages 767-776, OXFORD GB
  • CHEMICAL ABSTRACTS, vol. 92, no. 22, 2 June 1980 (1980-06-02) Columbus, Ohio, US; abstract no. 189424e, DEUTSCHER H. J. ET AL.: "Liquid-crystalline hydroquinone bis(trans-4-n-alkylcyclohexanecarboxylates )." page 559; column 2; XP002266803 & J. PRAKT. CHEM., vol. 321, no. 6, 1979, pages 969-977,
  • ZOE A. STEWART AND JENNIFER A. PIENTENPOL: "G2 Checkpoint and Anticancer Therapy" EUREKA, [Online] 25 January 2001 (2001-01-25), pages 1-28, XP002280757 Retrieved from the Internet: <URL:http://www.eurekah.com/pietenpol/> [retrieved on 2004-05-18]
  • ANTONIO M. SERAFIN ET AL.: "Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation" UROL RES, vol. 29, 2001, pages 221-227, XP002280758
  • PIERS EDWARD ET AL: "Improved Synthesis of Isogranulatimide, a G2 Checkpoint Inhibitor. Syntheses of Didemnimide C, Isodidemnimide A, Neodidemnimide A, 17-Methylgranulatimide, and Isogranulatimides A-C" JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 65, 28 January 2000 (2000-01-28), pages 530-535, XP002175370 ISSN: 0022-3263
  • YULI WANG ET AL. : "Radiosensitization of p53 Mutant cells by PD0166285, a novel G2 checkpoint abrogator" CANCER RESEARCH., vol. 61, 15 November 2001 (2001-11-15), pages 8211-8217, XP002280759 AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD., US ISSN: 0008-5472
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).